All Stories

  1. Association Between Endometriosis and Environmental Disruptors: A Literature Review and Meta-Analysis
  2. Insights from the Pre-Molecular Era in Advanced Endometrial Cancer: Benchmarking Prognostic Indicators in High-Risk Tumours
  3. Misleading Lesions in Gynecological Malignancies: A Case Report of Desmoid Tumor During Pregnancy and a Narrative Review of the Literature
  4. Fertility-sparing approach in endometrioid grade II endometrial cancer: the role of molecular classification
  5. Robotic-assisted single-port and multi-port surgical staging in early-stage endometrial cancer: a propensity matched comparison
  6. The role of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer
  7. Viral Infections of the Vulva: A Narrative Review
  8. Human Papillomavirus Across the Reproductive Lifespan: An Integrative Review of Fertility, Pregnancy Outcomes, and Fertility-Sparing Management
  9. Feasibility and safety of robotic single-port surgical staging in epithelial ovarian cancer using the da Vinci SP platform: a preliminary experience
  10. Efficacy, safety, and feasibility of the treatment of intrauterine pathologies with the hysteroscopic morcellator: A systematic review
  11. Evaluation of survival and mortality in pelvic exenteration for gynecologic malignancies: a systematic review, meta-analyses, and meta-regression study
  12. No Increased Risk of Autoimmune Diseases Following HPV Vaccination: A Systematic Review and Meta-Analysis
  13. Chemo-conization in Early-sTage cERvical caNcer >2 cm scheduled for fertilItY-sparing approach: an analysis of the ETERNITY project
  14. Impact of the FIGO 2023 Staging System on the Adjuvant Treatment of Endometrial Cancer: A Comparative Analysis with FIGO 2009
  15. Editorial: Diagnosis and treatment of vulvar cancer
  16. Surgical outcomes and morbidity in open and videoendoscopic inguinal lymphadenectomy in vulvar cancer: A systematic review and metanalysis”
  17. Precision and progress: minimally invasive surgery in gynaecologic cancer treatment
  18. Short- and long-term outcomes of vaginal, laparoscopic, and robotic-assisted surgery in “oldest old” endometrial cancer
  19. Impact of Ketogenic Diet on Weight, Metabolic, and Endocrine Parameters in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
  20. Editorial: Tailoring treatment in invasive and non-invasive cervical pathology volume II
  21. Uterine fibroid embolization: An analysis of clinical outcomes and impact on patients’ quality of life
  22. Laparoscopic prediction of primary cytoreducibility of epithelial ovarian cancer
  23. Minimally invasive vs. open surgery: comparison of surgical complications in radical hysterectomy for cervical cancer
  24. Update on Genitourinary Syndrome of Menopause: A Scoping Review of a Tailored Treatment-Based Approach
  25. Strategic Approaches in Management of Early-Stage Cervical Cancer: A Comprehensive Editorial
  26. The Role of Tumor Biomarkers in Tailoring the Approach to Advanced Ovarian Cancer
  27. Prognostic impact of microscopic residual disease after neoadjuvant chemotherapy in patients undergoing interval debulking surgery for advanced ovarian cancer
  28. What is the impact of simulation on the learning of hysteroscopic skills by residents and medical students? A systematic review
  29. Robotic-assisted, laparoscopic, and vaginal hysterectomy in morbidly obese patients with endometrial hyperplasia and endometrial cancer
  30. Rapid and random-start endometrial preparation before outpatient hysteroscopic polypectomy in patients of perimenopausal age
  31. Sentinel node mapping, sentinel node mapping plus back-up lymphadenectomy, and lymphadenectomy in Early-sTage cERvical caNcer scheduled for fertilItY-sparing approach: The ETERNITY project
  32. The role of artificial intelligence in cosmetic and functional gynecology: Stepping into the third millennium
  33. Hysteroscopy: where did we start, and where are we now? The compelling story of what many considered the “Cinderella” of gynecological endoscopy
  34. Role of V-Y flap reconstruction in vulvar cancer patients: multicenter retrospective study
  35. RETRACTED: The use of oral nomegestrol acetate/estradiol in rapid and random start preparation of endometrium before office hysteroscopic polypectomies: A multicenter, prospective, randomized controlled trial
  36. Sexual Function in Women Diagnosed with Hereditary Breast and Ovarian Cancer Syndrome
  37. Cold Knife Versus Carbon Dioxide for the Treatment of Preinvasive Cervical Lesion
  38. A bitter pill to swallow: adjustments to oral contraceptive pill use in polycystic ovary syndrome
  39. Precision Imaging in Cervical Cancer: A Comprehensive Approach to Diagnosis and Pre-treatment Evaluation
  40. The great debate: Surgical outcomes of laparoscopic versus laparotomic myomectomy. A meta-analysis to critically evaluate current evidence and look over the horizon
  41. State of the art on HPV-related cervical lesions
  42. Editorial: Early cervical cancer: laparotomic vs minimally invasive surgery and fertility-sparing possible strategies
  43. Approaches to prevention of gynecological malignancies
  44. Reproductive Outcomes in Young Women with Early-Stage Cervical Cancer Greater than 2 cm Undergoing Fertility-Sparing Treatment: A Systematic Review
  45. Effect of Maternal Age and Body Mass Index on Induction of Labor Using Oral Misoprostol in Late-Term Pregnancies: A Retrospective Cross-Sectional Study
  46. Sentinel node mapping in high-intermediate and high-risk endometrial cancer: Analysis of 5-year oncologic outcomes
  47. Deciphering the “David Sign”: Intersections in esthetic surgery and renaissance sculpture
  48. Health-related quality of life after hysterectomy for endometrial cancer: the impact of enhanced recovery after surgery (ERAS) shifting paradigm
  49. Placentation and complications of ART pregnancy. An update on the different possible etiopathogenic mechanisms involved in the development of obstetric complications
  50. Vulvar lipoma: rare case, rare location
  51. Safety and efficacy of a class II medical device based on highly purified and standardized plant extracts in the management of post-menopausal patients with vulvar and vaginal atrophy: a single-center prospective observational study
  52. Polycystic Ovary Syndrome and Alteration of Vocal Function: A Systematic Review and Meta-Analysis
  53. Editorial: Minimally invasive surgery in gynecology oncology: current trends and controversies
  54. Hormone replacement therapy in gynecological cancer survivors and BRCA mutation carriers: a MITO group survey
  55. Sentinel node mapping in endometrial cancer
  56. Targeting BRAF pathway in low-grade serous ovarian cancer
  57. Reproductive and oncologic outcomes in young women with uterine sarcoma undergoing fertility-sparing treatment: a systematic review
  58. Pharmacotherapy for the treatment of recurrent cervical cancer: an update of the literature
  59. Spotlight on Compounded Bioidentical Hormones
  60. Robotic vs. laparoscopic approach in obese patients with endometrial cancer: which is the best? A mini-review
  61. HPV-related lesions after hysterectomy for high-grade cervical intraepithelial neoplasia and early-stage cervical cancer: A focus on the potential role of vaccination
  62. Pathogenesis and Treatments of Endometrial Carcinoma
  63. Patterns of recurrence in FIGO stage IB1-IB2 cervical cancer: Comparison between minimally invasive and abdominal radical hysterectomy
  64. Laparoscopic Prediction of Primary Cytoreducibility of Epithelial Ovarian Cancer
  65. Management of Endometrial Cancer: Molecular Identikit and Tailored Therapeutic Approach
  66. HPV persistence after cervical surgical excision of high‐grade cervical lesions
  67. Intrapartum foetal heart rate decelerations are physiological adaptations to hypoxia: a critical appraisal of the recent evidence
  68. #427 Ten-year outcomes following laparoscopic and open abdominal radical hysterectomy for ‘low-risk’ early-stage cervical cancer: a propensity-score based analysis
  69. Prevention, Screening, Treatment and Follow-Up of Gynecological Cancers: State of Art and Future Perspectives
  70. Uterine sarcomas: A critical review of the literature
  71. The role of L1CAM as predictor of poor prognosis in stage I endometrial cancer: a systematic review and meta-analysis
  72. Therapeutic Approaches to Vulvar Cancer: A Review of Literature
  73. Androgens and Female Sexuality: Molecular Insights, Neuroendocrine Crosstalk and Future Therapeutic Directions
  74. Duration of human papillomavirus persistence and its relationship with recurrent cervical dysplasia
  75. Ten-year outcomes following laparoscopic and open abdominal radical hysterectomy for “low-risk” early-stage cervical cancer: A propensity-score based analysis
  76. PARP Inhibitors in Newly Diagnosed and Recurrent Ovarian Cancer
  77. Vulvodynia: A practical guide in treatment strategies
  78. Magnetic resonance imaging-radiomics in endometrial cancer: a systematic review and meta-analysis
  79. Sexual dysfunctions in breast cancer patients: evidence in context
  80. Outcomes of High-Grade Cervical Dysplasia with Positive Margins and HPV Persistence after Cervical Conization
  81. Recent Advances in Endometrial Cancer Management
  82. Novel Insights into Molecular Mechanisms of Endometrial Diseases
  83. Role of Genomic and Molecular Biology in the Modulation of the Treatment of Endometrial Cancer: Narrative Review and Perspectives
  84. Laparoscopic Versus Abdominal Radical Hysterectomy
  85. Learning Laparoscopic Radical Hysterectomy: Are We Facing an Emerging Situation?
  86. Effect of maternal age and body mass index on induction of labor with oral misoprostol for premature rupture of membrane at term: A retrospective cross-sectional study
  87. Obstructed Hemivagina and Ipsilateral Renal Anomaly Syndrome: A Systematic Review about Diagnosis and Surgical Management
  88. Use of botulinum toxin in aesthetic medicine and gynaecology: current approaches, controversies, and future directions
  89. Hysterectomy Using Vaginal Natural Orifice Transluminal Endoscopic Surgery Compared with Classic Laparoscopic Hysterectomy: A New Advantageous Approach? A Systematic Review on Surgical Outcomes
  90. Radiomics and Molecular Classification in Endometrial Cancer (The ROME Study): A Step Forward to a Simplified Precision Medicine
  91. Laparoscopic management of rudimentary uterine horns in patients with unicornuate uterus: a systematic review
  92. Recent Research on the Treatment of Vulvar and Vaginal Atrophy
  93. Hysterectomy: Let’s Step Up the Ladder of Evidence to Look Over the Horizon
  94. Personalized Treatment of Vulvar Cancer
  95. Evaluation of Surgical Outcomes of Abdominal Radical Hysterectomy and Total Laparoscopic Radical Hysterectomy for Cervical Cancer: A Retrospective Analysis of Data Collected before the LACC Trial
  96. Fractional Co2 laser for vulvo-vaginal atrophy in gynecologic cancer patients: A valid therapeutic choice? A systematic review
  97. Radical Hysterectomy for Early Stage Cervical Cancer
  98. The Efficacy of Fractional CO2 Laser in the Treatment of Genitourinary Syndrome of Menopause: A Large Prospective Observational Study
  99. Practice patterns and 90-day treatment-related morbidity in early-stage cervical cancer
  100. Advances on Prevention and Screening of Gynecologic Tumors: Are We Stepping Forward?
  101. Percutaneous-assisted laparoscopy for ovarian tissue cryopreservation: a single-center experience
  102. New Advances in Cervical Cancer: From Bench to Bedside
  103. Minimally Invasive Surgery for Cervical Cancer: Should We Look beyond Squamous Cell Carcinoma?
  104. Loop Electrosurgical Excision Procedure and Cold Knife Conization: which is the best? A large retrospective study
  105. The role of preoperative frailty assessment in patients affected by gynecological cancer: a narrative review
  106. Development of a Nomogram Predicting the Risk of Persistence/Recurrence of Cervical Dysplasia
  107. Predictors of Pain Development after Laparoscopic Adnexectomy: A Still Open Challenge
  108. HAPPY MAMA Project (Part 2)—Maternal Distress and Self-Efficacy: A Pilot Randomized Controlled Field Trial
  109. Molecular markers and endometrial cancer
  110. Age-Adjusted Charlson Comorbidity Index Predicts Survival in Endometrial Cancer Patients
  111. The giant steps in surgical downsizing toward a personalized treatment of vulvar cancer
  112. Prognostic Role of the Removed Vaginal Cuff and Its Correlation with L1CAM in Low-Risk Endometrial Adenocarcinoma
  113. Preoperative frailty assessment in patients undergoing gynecologic oncology surgery: A systematic review
  114. Reducing the radicality of surgery for vulvar cancer: are smaller margins safer?
  115. Relationship between cervical excisional treatment for cervical intraepithelial neoplasia and obstetrical outcome
  116. Update on surgical treatment of female stress urinary incontinence
  117. Modified fragility index and surgical complexity score are able to predict postoperative morbidity and mortality after cytoreductive surgery for advanced ovarian cancer
  118. Urinary incontinence in women: state of the art and medical treatment
  119. High-risk HPV-positive and -negative high-grade cervical dysplasia: Analysis of 5-year outcomes
  120. The role of the sentinel lymph node in vulvar cancer
  121. Assessing the Long-Term Role of Vaccination against HPV after Loop Electrosurgical Excision Procedure (LEEP): A Propensity-Score Matched Comparison
  122. Recurrence rate after loop electrosurgical excision procedure (LEEP) and laser Conization: A 5-year follow-up study
  123. The V‐Y gluteal fold advancement flap: Outcomes following radical surgery for vulvar malignancies
  124. Hepatobiliary Disease Resection in Patients with Advanced Epithelial Ovarian Cancer: Prognostic Role and Optimal Cytoreduction
  125. Safety evaluation of fractional CO2 laser treatment in post-menopausal women with vaginal atrophy: A prospective observational study
  126. New medical device containing verbascoside, carrageenan and glycerophosphoinositol for the treatment of dyspareunia in reproductive age women: A prospective observational study
  127. Myasthaenia gravis in pregnancy, delivery and newborn
  128. Lymphadenectomy in Ovarian Cancer: Is It Still Justified?
  129. Does hysterosalpingo-foam sonography have any therapeutic effect? A systematic review
  130. The use of misoprostol and mifepristone in second trimester interruption of pregnancy: State of art
  131. Predictors of postoperative overall and severe complications after surgical treatment for endometrial cancer: The role of the fragility index
  132. Complementemia in pregnancies with antiphospholipid syndrome
  133. Incidence of Neonatal Neutropenia, Leukopenia, and Anemia After In Utero Exposure to Chemotherapy For Maternal Cancer
  134. Lupus anticoagulant remission after gluten-free diet in a coeliac pregnant woman
  135. Vaginal Native Tissue Repair for Posterior Compartment Prolapse: Long-term Analysis of Sexual Function and Quality of Life in 151 Patients
  136. Vaginal Native Tissue Repair for Posterior Compartment Prolapse: Long-Term Analysis of Sexual Function and Quality of Life in 151 Patients
  137. Usefulness of Ospemifene in the treatment of urgency in menopausal patients affected by mixed urinary incontinence underwent mid-urethral slings surgery
  138. Antiphospholipid syndrome: An update on risk factors for pregnancy outcome
  139. Therapeutic vaccines and immune checkpoints inhibition options for gynecological cancers
  140. Overactive bladder syndrome treatment with ospemifene in menopausal patients with vulvovaginal atrophy: improvement of sexuality?
  141. Orally Administered Combination of Hyaluronic Acid, Chondroitin Sulfate, Curcumin, and Quercetin in the Prevention of Postcoital Recurrent Urinary Tract Infections: Analysis of 98 Women in Reproductive Age After 6 Months of Treatment
  142. Vulvo-vaginal reconstruction after radical excision for treatment of vulvar cancer: Evaluation of feasibility and morbidity of different surgical techniques
  143. A medical device containing purified bovine colostrum (Monurelle Biogel) in the treatment of vulvovaginal atrophy in postmenopausal women: Retrospective analysis of urinary symptoms, sexual function, and quality of life
  144. Retrospective analysis in 46 women with vulvovaginal atrophy treated with ospemifene for 12 weeks: improvement in overactive bladder symptoms
  145. Bevacizumab in Ovarian Cancer: State of the Art and Unanswered Questions
  146. Prognostic role of inguinal lymphadenectomy in vulvar squamous carcinoma: younger and older patients should be equally treated. A prospective study and literature review